Harvard Bioscience Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$577.39 | $591.94 | 6.51% | 1 | $220.40B |
| DHR | Danaher | Outperform |
10
|
$250.41 | $260.33 | 7.82% | 4 | $187.44B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$233.83 | $284.47 | 19.75% | 8 | $67.64B |
| LONN | Lonza Group | Buy |
16
|
CHF522.80 | CHF516.89 | 11.90% | 8 | CHF37.70B |
| BIO | Bio-Rad Laboratories Inc | Buy |
16
|
$278.21 | $536.80 | 56.97% | 1 | $8.76B |
| MXCT | MaxCyte | Buy |
8
|
£3.05 | £9.66 | 215.74% | 6 | £344.51M |